Related Experiment Video
Updated: Jan 7, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Hyperglycemia exacerbates placental inflammation induced by Porphyromonas gingivalis-lipopolysaccharide
María José Bendek1,2, María Luisa Mizgier2, Carolina Rojas2
1Faculty of Medicine, Doctoral Program in Biomedicine, Centre for Biomedical Research and Innovation, Universidad de los Andes, Santiago, Chile.
Background:
Epidemiological studies suggest a link between gestational diabetes mellitus (GDM) and periodontitis. In this context, Porphyromonas gingivalis (Pg) and its byproducts, including lipopolysaccharide (Pg-LPS), may translocate to the placenta, potentially intensifying pro-inflammatory mechanisms in a hyperglycemic environment. This study aimed to assess the pro-inflammatory simultaneous stimulus effect of hyperglycemia (HG) and Pg-LPS in human term placental explants.
Methods:
Fresh placental explants from healthy (n = 10) and GDM (n = 5) pregnant women were stimulated under normoglycemia (NG), hyperglycemia (HG), Pg-LPS, and a dual stimulus of HG+Pg-LPS. Both placental explants and culture supernatants were assessed using histology, real-time quantitative polymerase chain reaction (RT-qPCR), Western blot, immunofluorescence, and multiplex immunoassay to analyze histopathological alterations, Toll-like receptor (TLR)-2, -4, -9 mRNA expression, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) phosphorylation and nuclear immunolocalization, NLRP3 inflammasome expression, and pro-inflammatory cytokines (interleukin [IL]-6, IL-1β, and tumor necrosis factor [TNF]-α).
Results:
The dual stimulus (HG+Pg-LPS) increased fibrinoid necrosis (p < 0.05) and upregulated TLR-4 mRNA (p < 0.05) expression in placental explants, compared to other experimental conditions. NF-κB phosphorylation and nuclear immunolocalization, NLRP3 inflammasome and IL-6, IL-1β, and TNF-α mRNA expression increased upon the dual stimulus in healthy and GDM explants (p < 0.05). Additionally, levels of IL-6 (p < 0.01), IL-1β (p < 0.01), and TNF-α (p < 0.0001) increased in the supernatant from healthy and GDM explants under the dual stimulus. No differences in cytokine levels were observed between healthy and GDM placental explants under the dual stimulus.
Conclusions:
A hyperglycemic environment amplifies the pro-inflammatory response to Pg-LPS in human placental explants, suggesting that hyperglycemia synergizes with Pg-LPS in the placenta.
Plain Language Summary:
Bacteria that drive periodontitis, or their products, can enter the bloodstream and reach the placenta. In a high-glucose environment, this exposure can intensify placental inflammation. This study aimed to determine whether exposure to a high-glucose milieu, combined with byproducts of periodontal bacteria, activates inflammatory pathways in the placenta. Our results demonstrate that a high-glucose environment amplifies the inflammatory response to periodontal bacteria in human placentas from both healthy pregnancies and those complicated by gestational diabetes mellitus. These findings advance our understanding of the connection between periodontitis and gestational diabetes mellitus and underscore the role of oral bacterial translocation in placental tissues during pregnancy.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Hypoglycemia and Glucagon
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Acute Pancreatitis II: Clinical Manifestations and Management
Dipeptidyl Peptidase 4 Inhibitors

